Insiders · TVRD

TVRD insider transactions

Tvardi Therapeutics Inc. (TVRD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for TVRD

• 82d
  SEC Form 4 filed by Chief Financial Officer Conn Avi Daniel

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 82d
  SEC Form 4 filed by Principal Accounting Officer O'Brien Stephen Paul

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 82d
  SEC Form 4 filed by Chief Medical Officer Kauh John Saewook M.D.

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 82d
  SEC Form 4 filed by Chief Executive Officer Alibhai Imran Nizamudin

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 128d
  SEC Form 4 filed by Chief Executive Officer Alibhai Imran Nizamudin

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 128d
  SEC Form 4 filed by Chief Financial Officer Conn Avi Daniel

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 128d
  SEC Form 4 filed by Chief Medical Officer Kauh John Saewook M.D.

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 128d
  SEC Form 4 filed by Principal Accounting Officer O'Brien Stephen Paul

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 263d
  Large owner Tweardy Samuel David disposed of 631,316 shares (SEC Form 4)

  4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 358d
  Amendment: Director Hall Wallace L Jr was granted 246,756 shares (SEC Form 4)

  4/A - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 358d
  Amendment: Director Wirk Shaheen was granted 439,194 shares (SEC Form 4)

  4/A - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
• 358d
  New insider Tweardy Samuel David claimed ownership of 946,974 shares (SEC Form 3)

  3 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)